BBC新闻服务一直以其客观性、公正性和准确性而备受赞誉。多年来，BBC新闻以其高质量的新闻报道和深度分析，为观众提供了获取世界最新动态的重要渠道。整理了近期实时相关资讯：国药集团mpox疫苗获准进入临床试验的相关内容中英文对照版，帮助大家更好的学习英语！

英文原文

The country's top drug regulator has cleared a mpox vaccine developed by Chinese drugmaker Sinopharm for clinical trial on Monday, which could be the nation's first experimental dose to battle the deadly disease, according to the company.

据该公司介绍，周一，中国国家药品监督管理局已批准中国药企国药集团研发的mpox疫苗进入临床试验阶段，这可能是中国首款用于抗击这种致命疾病的试验性疫苗。

The domestic vaccine candidate, created by the Shanghai Institute of Biological Products and administered by Sinopharm, is expected to play an important role in preventing and controlling mpox infections, the company said in a statement released on Monday afternoon.

国药集团在周一下午发布的一份声明中表示，这款由上海生物制品研究所研制、国药集团负责管理的国产候选疫苗有望在预防和控制mpox感染方面发挥重要作用。

In China, a vaccine candidate typically goes through three phases of clinical trials before gaining market approval. The process can take years, even decades, but the National Medical Products Administration, China's top drug regulator, has launched a number of accelerated or streamlined channels to facilitate applications of novel drugs and vaccines or those in urgent need.

在中国，候选疫苗通常需要经过三个阶段的临床试验才能获得市场批准。这一流程可能需要数年甚至数十年时间，但中国国家药品监督管理局已开通多条加速或简化通道，以方便新药和疫苗或急需药品的申请。

According to the company, the new vaccine is a replication-deficient vaccine based on a strain called MVA. The description is the same as Jynneos, the world's first mpox vaccine approved by the Food and Drug Administration in the United States in 2019.

据该公司介绍，这款新疫苗是一种基于MVA毒株的复制缺陷型疫苗。其描述与美国食品药品监督管理局2019年批准的世界首款mpox疫苗Jynneos相同。

以上便是BBC新闻：国药集团mpox疫苗获准进入临床试验的相关内容！通过了解这则新闻，可以学习相关的英语词汇和短语。